The 9th Annual International Symposium of Drug Delivery Systems

Rescheduled Notice

With cases of Covid-19 reaching new heights in the world, some states have to adapt rapidly with their rules and regulations. After seeking advice from the some agency and venue hotel in Amsterdam, also considering the traffic control and epidemic prevention, the committee must admit this July is not a good time for holding an event. So after serious consideration, the organizing committee decides to postpone this meeting to next July at Amsterdam, the Netherlands.Sincerely hope you can understand such a demanded action.

Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.

Event Committee

Highlights

● Organize up to 200+ Oral Presentations on the Latest Tech Trend of Drug Delivery Systems
● 300+ Attendees Coming from All over the World to Exchange Ideas, Build New Networks, and Foster Friendships
● Bring together 50+ Project Posters on New Technologies Implemented in Industrial Manufacturing
● Learn Global Market Trends for Advanced Drug Delivery Systems
● Cutting-edge Keynote Addresses by Prominent Leaders from All over the World
● Opportunities to Visit the Netherlands's Natural and Cultural Landscapes

Keynote Speakers

	Dr. Luc Van Hijfte SVP Medicinal Chemistry, Symeres, the Netherlands		Dr. Matthias von Herrath Professor, La Jolla Institute; Vice President, NovoNordisk, USA
	Dr. Dan Some Principal Scientist, Wyatt Technology Corporation, USA		Dr. Balazs Sarkadi Professor, Semmelweis University, Hungary
	Dr. Uwe Schoenbeck, Senior Vice President & Chief Scientific Officer, Worldwide R & D, Pfizer, USA		Dr. Zsolt Bosnyak, VP, Global Medical Head Diabetes, Sanofi, France

Confirmed Renowned Speakers

Dr. Benno Rattel, Executive Director, Nonclinical Development, Amgen Research, Germany	Dr. Alexey RAK, Director of Bio Structure and Biophysics, Sanofi R&D, France	Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA
Dr. Marcus Bauser, Director, Medicinal Chemistry, Bayer AG, Germany	Dr. Finn Bauer, Global Head of Solid Formulations R&D, Merck KGaA, Germany	Dr. Florian Montel, Head of opnMe.com & CNS Project Leader, Boehringer Ingelheim, Germany
Dr. Henk Leeuwis, Vice President, LioniX International, the Netherlands	Dr. Miriam Kidron, CSO, Oramed Pharmaceuticals, Isreal	Dr. Ralf Glatthar, Director, Novartis Pharma AG, Switzerland
Dr. Steve Faraci, CSO, Cyta Therapeutics, USA	Dr. Frank Bartels, CEO, Bartels Mikrotechnik GmbH, Germany	Dr. Sandrine Gerber-Lemaire, Professor, EPFL Lausanne, Switzerland
Dr. Sam Dylan More, CEO, DendroPharm, Germany	Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd, UK	Dr. Karen S. Aboody, Professor, City of Hope National Medical Center & Beckman Research Institute, USA
Dr. Immanuel Lerner, Chief Executive Officer, Pepticom LTD, Isreal	Dr. Anthony W. Coleman, Research Director, Université de Lyon, France	Dr. Mircea Ciuca, Head, Medical Clinical Drug Safety, Vifor Pharma, Switzerland
Dr. Lucas P.J.J. Noldus, Founder & CEO, Noldus Information Technology bv, the Netherlands	Dr. Wilbur de Kruijf, VP, Medspray Pharma, the Netherlands	Dr. Hubert Pellikaan, Nextstep Pharma BV, the Netherlands
Dr. Faz Chowdhury, CEO, Nemaura Pharma Limited, UK	Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell, France	Dr. Khursheed Anwer, Executive Vice President & Chief Science Officer, Celsion Corporation, USA
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK	Dr. Michael Black, Head of Sales PHARMA, BENEO-Palatinit GmbH, Germany	Dr. Masha Poyurovsky, Vice President, Kadmon Corporation, LLC, USA
Dr. Yaakov Naparstek, Professor of Medicine, Hadassah University Hospital, Israel	Dr. Michael Reilly, Executive Director, Alliance for Safe Biologic Medicine, USA	Dr. Luana Pesco Koplowitz, Chief Medical & Scientific Officer, DUCK FLATS Pharma, USA
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd, UK	Dr. Lars Neumann, Director, Proteros biostructures GmbH, Germany	Dr. Raphael Serreau, Professor, Unité INSERM “Psycomadd“ Université Paris Sud, France
Dr. Sigrid Saaler-Reinhardt, Director, Midas Pharma GmbH, Germany	Dr. Monica Berrondo, CEO, Macromoltek - Molecular simulations simplified, USA	Dr. Andrea Cusack, CBO, Leon-nanodrugs GmbH, Germany

Dr. Benno Rattel, Executive Director, Nonclinical Development, Amgen Research, Germany	Dr. Alexey RAK, Director of Bio Structure and Biophysics, Sanofi R&D, France	Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA
Dr. Marcus Bauser, Director, Medicinal Chemistry, Bayer AG, Germany	Dr. Finn Bauer, Global Head of Solid Formulations R&D, Merck KGaA, Germany	Dr. Florian Montel, Head of opnMe.com & CNS Project Leader, Boehringer Ingelheim, Germany
Dr. Henk Leeuwis, Vice President, LioniX International, the Netherlands	Dr. Miriam Kidron, CSO, Oramed Pharmaceuticals, Isreal	Dr. Ralf Glatthar, Director, Novartis Pharma AG, Switzerland
Dr. Steve Faraci, CSO, Cyta Therapeutics, USA	Dr. Frank Bartels, CEO, Bartels Mikrotechnik GmbH, Germany	Dr. Sandrine Gerber-Lemaire, Professor, EPFL Lausanne, Switzerland
Dr. Sam Dylan More, CEO, DendroPharm, Germany	Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd, UK	Dr. Karen S. Aboody, Professor, City of Hope National Medical Center & Beckman Research Institute, USA
Dr. Immanuel Lerner, Chief Executive Officer, Pepticom LTD, Isreal	Dr. Anthony W. Coleman, Research Director, Université de Lyon, France	Dr. Mircea Ciuca, Head, Medical Clinical Drug Safety, Vifor Pharma, Switzerland
Dr. Lucas P.J.J. Noldus, Founder & CEO, Noldus Information Technology bv, the Netherlands	Dr. Wilbur de Kruijf, VP, Medspray Pharma, the Netherlands	Dr. Hubert Pellikaan, Nextstep Pharma BV, the Netherlands
Dr. Faz Chowdhury, CEO, Nemaura Pharma Limited, UK	Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell, France	Dr. Khursheed Anwer, Executive Vice President & Chief Science Officer, Celsion Corporation, USA
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK	Dr. Michael Black, Head of Sales PHARMA, BENEO-Palatinit GmbH, Germany	Dr. Masha Poyurovsky, Vice President, Kadmon Corporation, LLC, USA
Dr. Yaakov Naparstek, Professor of Medicine, Hadassah University Hospital, Israel	Dr. Michael Reilly, Executive Director, Alliance for Safe Biologic Medicine, USA	Dr. Luana Pesco Koplowitz, Chief Medical & Scientific Officer, DUCK FLATS Pharma, USA
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd, UK	Dr. Lars Neumann, Director, Proteros biostructures GmbH, Germany	Dr. Raphael Serreau, Professor, Unité INSERM “Psycomadd“ Université Paris Sud, France
Dr. Sigrid Saaler-Reinhardt, Director, Midas Pharma GmbH, Germany	Dr. Monica Berrondo, CEO, Macromoltek - Molecular simulations simplified, USA	Dr. Andrea Cusack, CBO, Leon-nanodrugs GmbH, Germany

Exhibition and Posters

SDDS-2021 provides an ideal platform to showcase your novel technologies and products in the Netherlands. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at SDDS-2021
• Meet with International Leaders and Senior Officers in the Field of Drug Delivery Systems
• Maximize Your Opportunities for Collaboration
• Explore Business Opportunities in Amsterdam and beyond
• Spotlight Your Technologies and Its Commercial Application
• Superior Networking Opportunities with Senior Professionals and Industry Elites

Exhibition Date:
Set-up date: July 14, 2021
Show dates: July 15-17, 2021
Place: Amsterdam, the Netherlands

Introduction to Amsterdam

Amsterdam is the capital city and most populous municipality of the Netherlands. Its status as the capital is mandated by the Constitution of the Netherlands. Amsterdam's main attractions include its historic canals, the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum, Hermitage Amsterdam, the Anne Frank House, the Scheepvaartmuseum, the Amsterdam Museum, the Heineken Experience, the Royal Palace of Amsterdam, Natura Artis Magistra, Hortus Botanicus Amsterdam, NEMO, the red-light district and many cannabis coffee shops. They draw more than 5 million international visitors annually. The city is also well known for its nightlife and festival activity; several of its nightclubs (Melkweg, Paradiso) are among the world's most famous. It is also one of the world's most multicultural cities, with at least 177 nationalities represented.